Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1986-03-07
1990-06-19
Warden, Robert J.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
436548, 436817, 530387, 530809, 935110, G01N 33574, G01N 33577
Patent
active
049353446
ABSTRACT:
Antigenic profiles of renal carcinoma specimans developed with panels of monoclonal antibodies derived from several different tissues serve as useful clinical indicators for cancer type, cancer subset as well as histiogenesis and prognosis indicators.
REFERENCES:
patent: 4579827 (1986-04-01), Sakamoto et al.
patent: 4643971 (1987-02-01), Fradet et al.
patent: 4650756 (1987-03-01), Old et al.
patent: 4713352 (1987-12-01), Bander et al.
C. L. Finstad et al, Chem. Abs., 102, 21940x, 1985.
Y. Fradet et al, Proc. Natl. Acad. Sci (U.S.A.), 81, 224-228, 1984.
A. N. Houghton et al, Journ. Exp. Medicine, 156, 1755-1766, 1982.
B. Ueda et al, Proc. Natl. Acad. Sci. (U.S.A.), 78, 5122-5126, 1981.
Finstad et al, Proc. Natl. Acad. Sci., 82, 2955-2959, 1985.
Bander Neil H.
Cordon-Cardo Carlos
Finstad Connie L.
Melamed Myron R.
Oettgen Herbert F.
Saunders David A.
Sloan-Kettering Institute for Cancer Research
Warden Robert J.
White John P.
LandOfFree
Method for characterizing types of renal carcinoma and prognosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for characterizing types of renal carcinoma and prognosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for characterizing types of renal carcinoma and prognosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2260092